The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

K Dheda, T Perumal, H Moultrie, R Perumal… - The Lancet …, 2022 - thelancet.com
The global tuberculosis burden remains substantial, with more than 10 million people newly
ill per year. Nevertheless, tuberculosis incidence has slowly declined over the past decade …

[HTML][HTML] Virtual healthcare services and digital health technologies deployed during coronavirus disease 2019 (COVID-19) pandemic in South Africa: a systematic …

E Mbunge, J Batani, G Gaobotse, B Muchemwa - Global health journal, 2022 - Elsevier
Aims To identify virtual healthcare services and digital health technologies deployed in
South Africa during coronavirus disease 2019 (COVID-19) and the challenges associated …

Population immunity and Covid-19 severity with Omicron variant in South Africa

SA Madhi, G Kwatra, JE Myers, W Jassat… - … England Journal of …, 2022 - Mass Medical Soc
Abstract Background The B. 1.1. 529 (omicron) variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng …

Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study

W Jassat, SSA Karim, C Mudara, R Welch… - The Lancet Global …, 2022 - thelancet.com
Background Up to the end of January, 2022, South Africa has had four recognisable COVID-
19 pandemic waves, each predominantly dominated by one variant of concern: the ancestral …

Outcomes of laboratory‐confirmed SARS‐CoV‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South …

MA Davies, R Kassanjee, P Rousseau… - Tropical Medicine & …, 2022 - Wiley Online Library
OBJECTIVES The objective was to compare COVID‐19 outcomes in the Omicron‐driven
fourth wave with prior waves in the Western Cape, assess the contribution of undiagnosed …

SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21

C Cohen, J Kleynhans, A von Gottberg… - The Lancet Infectious …, 2022 - thelancet.com
Summary Background By August, 2021, South Africa had been affected by three waves of
SARS-CoV-2; the second associated with the beta variant and the third with the delta …

[HTML][HTML] SARS-CoV-2 seroprevalence in a rural and urban household cohort during first and second waves of infections, South Africa, July 2020–March 2021

J Kleynhans, S Tempia, N Wolter… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be
underestimated because of limited access to testing. We measured SARS-CoV-2 …

Effectiveness of the Ad26. COV2. S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B …

LG Bekker, N Garrett, A Goga, L Fairall, T Reddy… - The Lancet, 2022 - thelancet.com
Background We aimed to assess the effectiveness of a single dose of the Ad26. COV2. S
vaccine (Johnson & Johnson) in health-care workers in South Africa during two waves of the …

SARS-CoV-2: evolution and emergence of new viral variants

VR Flores-Vega, JV Monroy-Molina… - Viruses, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent
responsible for the coronavirus disease 2019 (COVID-19). The high rate of mutation of this …

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences

A Aiello, S Najafi-Fard, D Goletti - Frontiers in Immunology, 2023 - frontiersin.org
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …